发明授权
- 专利标题： Compounds and compositions as protein kinase inhibitors
- 专利标题（中）： 化合物和组合物作为蛋白激酶抑制剂
-
申请号： US14022540申请日： 2013-09-10
-
公开(公告)号： US08859548B2公开(公告)日： 2014-10-14
- 发明人: Abran Q. Costales , Shenlin Huang , Jeff Xianming Jin , Zuosheng Liu , Sabina Pecchi , Daniel Poon , John Tellew , Qiong Zhang
- 申请人： Abran Q. Costales , Shenlin Huang , Jeff Xianming Jin , Zuosheng Liu , Sabina Pecchi , Daniel Poon , John Tellew , Qiong Zhang
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 代理商 Scott W. Reid
- 主分类号： A61K31/50
- IPC分类号： A61K31/50 ; A61K45/06 ; A61K31/506 ; C07D403/04
摘要：
The present invention provides compounds of Formula I or II: wherein R1, R1b, R2, R3, R4, R5, R6 and R7 are defined herein. The compounds of Formula (I) or (II) and pharmaceutical compositions thereof are useful for the treatment of B-Raf-associated diseases.
公开/授权文献
- US20140011825A1 Compounds and Compositions as Protein Kinase Inhibitors 公开/授权日：2014-01-09
信息查询
